Skip to content

13F-HR filed by Prosight Management, LP

Prosight Management, LP filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-14, with 31 holding rows worth $159,449,000.

Accession
0001420506-18-000462
Filed
2018-05-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2018

A holdings report, 32 entries on the cover page, a total value of $159,449,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $159,449,000 with VALUE read as thousands by filing date, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SHIRE PLC82481R106COMMON STOCK-FO146,114$21,828,000thousands by filing date
ALLERGAN PLCG0177J108SHS94,800$15,954,000thousands by filing date
MACROGENICS INC556099109COM445,000$11,196,000thousands by filing date
SABRA HEALTH CARE REIT INC COM78573L106REIT580,000$10,237,000thousands by filing date
ACHAOGEN INC004449104COM661,054$8,561,000thousands by filing date
TELIGENT INC NEW87960W104COM2,472,561$8,308,000thousands by filing date
ALMOST FAMILY INC020409108COM135,000$7,560,000thousands by filing date
REATA PHARMACEUTICALS INC75615P103CL A297,750$6,107,000thousands by filing date
CIGNA CORPORATION125509109COM32,200$5,401,000thousands by filing date
SIERRA ONCOLOGY INC82640U107COM2,538,525$5,255,000thousands by filing date
EIGER BIOPHARMACEUTICALS INC28249U105COM530,848$5,229,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM63,400$5,140,000thousands by filing date
DEXCOM INC COM252131107Stock65,000$4,820,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW120,400$4,756,000thousands by filing date
CIDARA THERAPEUTICS INC COM NEW171757107Stock1,186,355$4,746,000thousands by filing date
PIERIS PHARMACEUTICALS INC720795103COM563,763$3,845,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM209,842$3,546,000thousands by filing date
INOGEN INC45780L954PUT26,800$3,292,000thousands by filing dateput
QUOTIENT LTDG73268107SHS682,180$3,213,000thousands by filing date
AVEO PHARMACEUTICALS INC053588109COM1,043,550$3,026,000thousands by filing date
CLOVIS ONCOLOGY INC189464900CALL50,000$2,640,000thousands by filing datecall
CIVITAS SOLUTIONS INC17887R102COM164,396$2,532,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock23,375$2,498,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM46,001$2,429,000thousands by filing date
PARATEK PHARMACEUTICALS INC699374302Equity148,682$1,933,000thousands by filing date
KINDRED HEALTHCARE INC494580103COM162,326$1,485,000thousands by filing date
NABRIVA THERAPEUTICS PLCG63637105SHS242,689$1,221,000thousands by filing date
NOVELION THERAPEUTICS INC67001K202COM NEW233,003$816,000thousands by filing date
UNIQURE NVN90064101SHS34,100$801,000thousands by filing date
BELLICUM PHARMACEUTICALS INC079481107COM106,050$696,000thousands by filing date
Ampio Pharmaceuticals03209T109COM111,150$378,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-18-000462this filing2018-05-14acceptance time not in the bulk data set